Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The gut microbiota plays a modifiable role in MS progression-YES.
Dose-Dependent Effects of Minocycline on Facial Nerve Regeneration: A Microscopic and Molecular Study.
Colorectal cancer screening in individuals with multiple sclerosis: A mixed-methods study.
[Ureaplasma infections in the immunocompromised patient].
Recombinant rat heat shock protein 70 (rrHSP70) may promote remyelination by regulating microglia/macrophages and oligodendrocytes in a toxin-induced demyelination animal model.
Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration.
Mapping the immune-genetic architecture of Epstein-Barr virus-related phenotypes and multiple sclerosis through a single-cell genetic framework for target prioritization and pharmacologic hypothesis generation.
[Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)].
Emergency department use before multiple sclerosis: Presenting complaints and discharge diagnoses.
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.
Fifteen-Year Longitudinal Changes in Peripapillary Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis.
PARP inhibition attenuates neuroinflammation and demyelination in a rat model of multiple sclerosis: A longitudinal [C]PBR28 TSPO PET imaging study.
Disease characteristics of SEPSECS deficiency: an international, retrospective, multicenter cohort study.
Sex-dependent protective effects of microglial tumor necrosis factor on post-stroke inflammation and myelin injury.
Bibliometric and visualization analysis of arginine deiminase research from 2006 to 2025: trends, collaboration networks and emerging frontiers.
Impact of age at onset on relapse-associated and relapse-independent disability accrual trajectories in multiple sclerosis.
The gut microbiome plays a modifiable role in MS progression-No.
Increased exertion variability is linked to disruptions in effort assessment in multiple sclerosis.
Tolebrutinib in nonrelapsing SPMS: regulatory divergence and the limits of relapse based labels.
Nonsystemic Vasculitic Neuropathy Presenting as Inflammatory Demyelinating Polyradiculoneuropathy.
Leveraging chimeric antigen receptor-T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology.
Peripheral neuropathies associated with immunoglobulin M monoclonal gammopathies and low-grade B-cell lymphomas: diagnostic and therapeutic approach.
Queer Science and Scientists Are Shaping the Future of Immunology.
Neurofascin Antibodies in a Large Cohort of Inflammatory Neuropathies from India.

Pages